CinCor Pharma
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. over the previous period. Total operating expenses were $42,510,406.
Profit Margin
| 2019 | 0 | -4.93M | |
|---|---|---|---|
| 2020 | 0 | -22.26M | |
| 2021 | 0 | -50.34M |
CINC Income Statement (2019 – 2021)
| 2021 | 2020 | 2019 | |
|---|---|---|---|
Revenue | |||
Revenue | 0 | 0 | 0 |
Cost of revenue | 0 | 0 | 0 |
Gross profit | 0 | 0 | 0 |
Operating exp. | |||
Research and development | 21.51M | 17.95M | 3.92M |
Selling and marketing | 0 | 0 | 0 |
Total operating expenses | 42.51M | 21.12M | 5.13M |
Operating income | -42.51M | -21.12M | -5.13M |
Other income (expenses), net | -7.85M | -1.17M | 101.70K |
Income before tax | -50.36M | -22.29M | -5.03M |
Income tax expense | -21.64K | -36.72K | -101.70K |
Net income | -50.34M | -22.26M | -4.93M |
Earnings per share | |||
Basic EPS | -1.42 | -0.95 | -0.21 |
Diluted EPS | -1.42 | -0.95 | -0.21 |
| Data source |